Table 3 Pathological features and Immunohistochemical stains (Primary site)
From: Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases
Case | FIGO stage | LVSI (Ly V) | Grade | Mytosis /10 HPF | Sarcomatous component | SO | Myoinvasion | SMARCA4 | BCOR | ER | PR | CD10 | P53 | MIB-1 (%) | Cyclin D1 | Cytokeratin | Desmin | SMA | other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recurrent cases | |||||||||||||||||||
1 | IC | + + | High | 5 | homologous | + | > 1 | + | – | – | – | – | Over express | 70 | – | – | – | – | CD34(−) S100(−) |
2 | IB | – | High | 10–15 | homologous | + | < 1/2 | + | + | – | – | + | Wild type | 50 | + | – | – | – | HHF35(−) CD34(−) S100(−) |
3 | IB | – | High | 10 | homologous | + | < 1/2 | + | – | – | – | + | Over express | 50 | – | ND | + | + | HHF35(+) |
4 | IC | + − | High | 30 | heterogenous | + | > 1/2 | + | ND | – | – | ND | Over express | ND | – | ND | ND | ND | |
Non-recurrent cases | |||||||||||||||||||
5 | IB | – | High | 5 | homologous | + | < 1/2 | + | – | – | – | + | Wild type | 30 | + | – | + | ND | |
6 | IB | – | Low | 3 | homologous | – | < 1/2 | + | – | + | + | – | Wild type | 5 | – | ND | – | ND | |
7 | IC | – | Low | 2 | homologous | – | > 1/2 | + | ND | + | + | ND | Null | ND | + | ND | ND | ND | |